4//SEC Filing
Akamine Scott 4
Accession 0000899243-22-005933
CIK 0001805387other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 6:43 PM ET
Size
5.5 KB
Accession
0000899243-22-005933
Insider Transaction Report
Form 4
Akamine Scott
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-09+58,572→ 58,572 totalExercise: $30.36Exp: 2032-02-09→ Common Stock (58,572 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on February 9, 2023, with the remainder vesting in thirty-six (36) monthly installments thereafter.
Documents
Issuer
Cerevel Therapeutics Holdings, Inc.
CIK 0001805387
Entity typeother
Related Parties
1- filerCIK 0001816720
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 6:43 PM ET
- Size
- 5.5 KB